Page 219 - Pagetit
P. 219

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia.
                   Hippocampus, 11:520–528.
                   Heilig M, Widerlov E (1990) Neuropeptide Y: an overview of central distribution,
                   functional aspects, and possible involvement in neuropsychiatric illnesses. Acta
                   Psychiatrica Scandinavica, 82:95–114.
                   Heilig M et al. (1994) Corticotropin-releasing factor and neuropeptide Y: role in
                   emotional integration. Trends in Neuroscience, 17:80–85.
                   Hendrie CA, Sairally J, Starkey N (1998) Self-medication with alcohol appears
                   not to be an effective treatment for the control of depression. Journal of
                   Psychopharmacology, 12:108.
                   Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theory of
                   depression: a modulatory role for monoamines, based on new findings from
                   monoamine depletion experiments in humans. Pharmacopsychiatry, 29:2–11.
                   Henningfield JE, Johnson RE, Jasinski DR (1987) Clinical procedures for the
                   assessment of abuse potential. In: Bozarth MA, ed. Methods of assessing the
                   reinforcing properties of abused drugs. New York, NY, Springer-Verlag:573–590.
                   Himmelsbach CK (1943) Can the euphoric, analgetic, and physical dependence
                   effects of drugs be separated? IV. With reference to physical dependence.
                   Federation Proceedings, 2:201–203.
                   Hitsman B et al. (1999) Antidepressant pharmacotherapy helps some cigarette
                   smokers more than others. Journal of Consulting and Clinical Psychology, 67:547–
                   554.
                   Holden C (2001) Drug addiction: zapping memory center triggers drug craving.
                   Science, 292:1039.
                   Hughes JR (1992) Tobacco withdrawal in self-quitters. Journal of Consulting and
                   Clinical Psychology, 60:689–697.
                   Hughes JR (1996) The future of smoking cessation therapy in the United States.
                   Addiction, 91:1797–1802.
                   Hughes JR, Hatsukami D (1992) The nicotine withdrawal syndrome: a brief review
                   and update. International Journal on Smoking Cessation, 1:21–26.
                   Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus other drug
                   withdrawal syndromes: similarities and dissimilarities. Addiction, 89:1461–1470.
                   Hughes JR et al. (1984) Effect of nicotine on the tobacco withdrawal syndrome.
                   Psychopharmacology, 83:82–87.
                   Hughes JR et al. (1986) Prevalence of smoking among psychiatric outpatients.
                   American Journal of Psychiatry, 143:993–997.
                   Hughes JR et al. (1991) Symptoms of tobacco withdrawal: a replication and
                   extension. Archives of General Psychiatry, 48:52–59.
                   Hurt RD et al. (1997) A comparison of sustained-release buproprion and placebo
                   for smoking cessation. New England Journal of Medicine, 337:1195–1202.
                   Imperato A et al. (1992) Chronic cocaine alters extracellular dopamine:
                   neurochemical basis for addiction. European Journal of Pharmacology, 212:299–
                   300.


                                                  198




          Chapter_6                198                             19.1.2004, 11:49
   214   215   216   217   218   219   220   221   222   223   224